Bitcoin Price Rebound: Liquidity Sensitivity Leads Market Recovery
- Arthur Hayes sees potential rebound amid banking strains.
- Bitcoin fell significantly but rebounded quickly.
- Exchanges faced infrastructural challenges during high volatility.
Bitcoin remains the most sensitive asset to liquidity changes, often leading market rebounds. October 2025 highlights include a swift price recovery from $104,000 to $115,000 and significant leveraged position liquidations totaling over $19 billion.
Bitcoin’s position as a leader during liquidity-driven recovery phases matters due to its impact on market confidence and trading activity.
Bitcoin, identified as the most sensitive cryptocurrency to liquidity changes, led price recoveries in October 2025. Bitcoin’s price dropped below $104,000 but swiftly rebounded to $113,000-$115,000.
“If regional banking strains escalate, we could see a scenario similar to 2023, with bailouts fueling a strong rebound”, stated Arthur Hayes, BitMEX Co-Founder, encouraging buying Bitcoin amid low prices. Arthur Hayes on Bitcoin Rebound . Binance allocated $283 million to users after system stress. Exchanges experienced challenges, prompting platform compensations.
Bitcoin’s rebound enhances investor confidence and renews interest in altcoins and related assets. Institutional players partially re-engaged with the market. On-chain data reveals high liquidation volumes.
Liquidity events have historically impacted Bitcoin, akin to past market corrections. Potential outcomes include tightened leverage protocols and enhanced liquidity management strategies across exchanges to mitigate future risks.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors
- Solana's 30% price drop in late 2025 contrasts with strong on-chain metrics like 400ms finality and $35.9B DEX volume, but declining user engagement and rising NVT ratios signaled overvaluation. - Macroeconomic factors including high interest rates and institutional caution reduced speculative demand, with ETF inflows favoring staking products over direct price support. - Whale accumulation and RWA growth (up 350% YoY) suggest strategic buying during dips, though active address recovery and NVT normaliza

The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects
- Global dementia cases surge to 55M in 2025, projected to triple to 139M by 2050 due to aging populations and Alzheimer's rise. - U.S. dementia costs hit $781B in 2025, with Medicare/Medicaid covering $164B and families paying $52B out-of-pocket. - Home healthcare and AI caregiver tech markets grow rapidly (10-17% CAGR), reaching $381B and $5.3B by 2033-2032 respectively. - Dementia biotech faces risks but attracts $3.1B in Q3 2025 venture funding (+70.9% QoQ), despite $161M losses at Alector/Denali. - St

Bitcoin Leverage Liquidation: Is This a Warning Sign for Individual Investors?
- Q3 2025 saw record $73.59B in crypto leverage, with $19B wiped in single-day Bitcoin liquidations on Oct 10. - Over-leveraging driven by FOMO and social media hype triggered panic selling via ADL mechanisms on major exchanges. - Automated risk controls prevented insolvency but exposed systemic fragility amid rapid price swings and emotional trading. - Experts urge retail investors to adopt strict leverage limits, stop-loss orders, and AI-driven analytics for disciplined risk management. - Regulatory scru
